|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
53,543,000 |
Market
Cap: |
11.13(B) |
Last
Volume: |
742,051 |
Avg
Vol: |
474,459 |
52
Week Range: |
$164.52 - $273.43 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 400 MIDCAP |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 456 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Charles River Laboratories International is a contract research organization. Co. has a laboratory animal medicine and science to develop a portfolio of discovery and safety assessment services. Co.'s segments include: Research Models and Services, which supplies research models to the drug development industry; Discovery and Safety Assessment (DSA), which provides DSA services, including in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development; Manufacturing Support, which ensure the safe production and release of products manufactured by Co.'s clients.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
7,942 |
11,192 |
Total Buy Value |
$0 |
$0 |
$1,447,725 |
$2,162,353 |
Total People Bought |
0 |
0 |
3 |
3 |
Total Buy Transactions |
0 |
0 |
3 |
5 |
Total Shares Sold |
6,002 |
31,084 |
49,996 |
92,833 |
Total Sell Value |
$1,524,396 |
$7,621,206 |
$11,292,577 |
$21,658,880 |
Total People Sold |
3 |
6 |
6 |
8 |
Total Sell Transactions |
5 |
11 |
16 |
28 |
End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Parisotto Shannon M |
CEVP, Disc & Safety Assessment |
|
2023-01-27 |
4 |
A |
$0.00 |
$0 |
D/D |
4,820 |
7,319 |
|
- |
|
Laplume Joseph W |
EVP, Corp Strategy & Develop |
|
2023-01-27 |
4 |
D |
$244.29 |
$796,630 |
D/D |
(3,261) |
25,647 |
|
- |
|
Laplume Joseph W |
EVP, Corp Strategy & Develop |
|
2023-01-27 |
4 |
A |
$0.00 |
$0 |
D/D |
8,676 |
28,908 |
|
- |
|
Girshick Birgit |
Corporate Executive VP & COO |
|
2023-01-27 |
4 |
D |
$244.29 |
$770,246 |
D/D |
(3,153) |
41,038 |
|
- |
|
Girshick Birgit |
Corporate Executive VP & COO |
|
2023-01-27 |
4 |
A |
$0.00 |
$0 |
D/D |
8,435 |
44,191 |
|
- |
|
Knell Michael Gunnar |
CSVP&Chief Accounting Officer |
|
2023-01-27 |
4 |
D |
$244.29 |
$157,567 |
D/D |
(645) |
7,889 |
|
- |
|
Knell Michael Gunnar |
CSVP&Chief Accounting Officer |
|
2023-01-27 |
4 |
A |
$0.00 |
$0 |
D/D |
2,096 |
8,534 |
|
- |
|
Thompson Craig B. |
Director |
|
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
244 |
244 |
|
- |
|
Wallman Richard F |
Director |
|
2022-12-02 |
4 |
B |
$218.90 |
$328,350 |
D/D |
1,500 |
20,114 |
2.39 |
-9% |
|
Barbo William D |
Corporate Executive VP & CCO |
|
2022-12-02 |
4 |
S |
$218.28 |
$704,814 |
D/D |
(3,205) |
3,803 |
|
9% |
|
Barbo William D |
Corporate Executive VP & CCO |
|
2022-12-02 |
4 |
OE |
$109.34 |
$350,435 |
D/D |
3,205 |
7,008 |
|
- |
|
Laplume Joseph W |
EVP, Corp Strategy & Develop |
|
2022-12-01 |
4 |
S |
$223.06 |
$1,437,205 |
D/D |
(6,409) |
20,232 |
|
9% |
|
Laplume Joseph W |
EVP, Corp Strategy & Develop |
|
2022-12-01 |
4 |
OE |
$109.34 |
$700,760 |
D/D |
6,409 |
26,641 |
|
- |
|
Knell Michael Gunnar |
CSVP&Chief Accounting Officer |
|
2022-11-16 |
4 |
S |
$248.59 |
$212,544 |
D/D |
(855) |
6,438 |
|
17% |
|
Knell Michael Gunnar |
CSVP&Chief Accounting Officer |
|
2022-11-16 |
4 |
OE |
$109.34 |
$93,486 |
D/D |
855 |
7,293 |
|
- |
|
Barbo William D |
Corporate Executive VP & CCO |
|
2022-11-15 |
4 |
GD |
$0.00 |
$0 |
I/I |
200 |
19,035 |
|
- |
|
Parisotto Shannon M |
CEVP, Disc & Safety Assessment |
|
2022-11-15 |
4 |
AS |
$249.90 |
$569,522 |
D/D |
(2,279) |
2,499 |
|
-21% |
|
Parisotto Shannon M |
CEVP, Disc & Safety Assessment |
|
2022-11-15 |
4 |
OE |
$109.34 |
$249,186 |
D/D |
2,279 |
4,778 |
|
- |
|
Laplume Joseph W |
EVP, Corp Strategy & Develop |
|
2022-11-04 |
4 |
S |
$216.36 |
$115,536 |
D/D |
(534) |
20,232 |
|
13% |
|
Parisotto Shannon M |
CEVP, Disc & Safety Assessment |
|
2022-10-24 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
29,036 |
|
9% |
|
Parisotto Shannon M |
CEVP, Disc & Safety Assessment |
|
2022-10-24 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,499 |
|
9% |
|
Laplume Joseph W |
EVP, Corp Strategy & Develop |
|
2022-08-05 |
4 |
S |
$226.13 |
$45,227 |
D/D |
(200) |
20,766 |
|
4% |
|
Laplume Joseph W |
EVP, Corp Strategy & Develop |
|
2022-07-06 |
4 |
GD |
$0.00 |
$0 |
D/D |
195 |
20,966 |
|
- |
|
Barbo William D |
Corporate Executive VP & CCO |
|
2022-06-07 |
4 |
GA |
$0.00 |
$0 |
I/I |
391 |
19,235 |
|
- |
|
Barbo William D |
Corporate Executive VP & CCO |
|
2022-06-07 |
4 |
GD |
$0.00 |
$0 |
D/D |
391 |
3,803 |
|
- |
|
2064 Records found
|
|
Page 8 of 83 |
|
|